Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Jani

Showing results (131-140 of 163) with videos related to

Pageof 17
Sort By:
Journal of Molecular and Cellular Cardiology|October 20, 2024
Cardiomyocyte myofilament function in common animal models of heart failure with preserved ejection fractionVivek P Jani, Navid Koleini, Axel J Fenwick, et al.
Journal of the American Society of Cytopathology|July 16, 2022
The optimal approach of EBUS-FNA rapid on-site evaluation (ROSE): a five-year experience from a large academic medical centerShaimaa Elzamly, Ali Al-Habib, Eman A Toraih, et al.
Molecular Cancer Therapeutics|June 10, 2010
Evaluation of selective gamma-secretase inhibitor PF-03084014 for its antitumor efficacy and gastrointestinal safety to guide optimal clinical trial designPing Wei, Marlena Walls, Ming Qiu, et al.
Echocardiography (Mount Kisco, N.Y.)|May 25, 2026
The Clinical Role and Impact of Dobutamine Stress Echocardiography in Liver TransplantationJim Lu, Richard A Ferraro, Garrett Goldin, et al.
BMJ Military Health|April 7, 2023
Health measurement instruments and their applicability to military veterans: a systematic reviewJane Jomy, P Jani, F Sheikh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 1998
Cell cycle-independent death of prostate adenocarcinoma is induced by the trk tyrosine kinase inhibitor CEP-751 (KT6587)C A Dionne, A M Camoratto, J P Jani, et al.
International Journal of Cancer|August 7, 1997
CEP-751 inhibits TRK receptor tyrosine kinase activity in vitro exhibits anti-tumor activityA M Camoratto, J P Jani, T S Angeles, et al.
Journal of Cardiac Failure|April 27, 2023
Modification of a Transvalvular Microaxial Flow Pump for Instantaneous Determination of Native Cardiac Output and VolumeM Imran Aslam, Aleksandra B Gruslova, Ahmed Almomani, et al.
Medrxiv : the Preprint Server for Health Sciences|June 12, 2025
Development of Computational Pipeline for Right Ventricular Hemodynamic Single-Beat AnalysisGyeongtae S Moon, Paul J Scheel, Maggie Montovano, et al.
Journal of the American Heart Association|January 9, 2024
Common Heart Failure With Preserved Ejection Fraction Animal Models Yield Disparate Myofibril MechanicsAxel J Fenwick, Vivek P Jani, D Brian Foster, et al.
Pageof 17

Showing results (131-140 of 163) with videos related to

Sort By:
Pageof 17
Journal of Molecular and Cellular Cardiology|October 20, 2024
Cardiomyocyte myofilament function in common animal models of heart failure with preserved ejection fractionVivek P Jani, Navid Koleini, Axel J Fenwick, et al.
Journal of the American Society of Cytopathology|July 16, 2022
The optimal approach of EBUS-FNA rapid on-site evaluation (ROSE): a five-year experience from a large academic medical centerShaimaa Elzamly, Ali Al-Habib, Eman A Toraih, et al.
Molecular Cancer Therapeutics|June 10, 2010
Evaluation of selective gamma-secretase inhibitor PF-03084014 for its antitumor efficacy and gastrointestinal safety to guide optimal clinical trial designPing Wei, Marlena Walls, Ming Qiu, et al.
Echocardiography (Mount Kisco, N.Y.)|May 25, 2026
The Clinical Role and Impact of Dobutamine Stress Echocardiography in Liver TransplantationJim Lu, Richard A Ferraro, Garrett Goldin, et al.
BMJ Military Health|April 7, 2023
Health measurement instruments and their applicability to military veterans: a systematic reviewJane Jomy, P Jani, F Sheikh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 1998
Cell cycle-independent death of prostate adenocarcinoma is induced by the trk tyrosine kinase inhibitor CEP-751 (KT6587)C A Dionne, A M Camoratto, J P Jani, et al.
International Journal of Cancer|August 7, 1997
CEP-751 inhibits TRK receptor tyrosine kinase activity in vitro exhibits anti-tumor activityA M Camoratto, J P Jani, T S Angeles, et al.
Journal of Cardiac Failure|April 27, 2023
Modification of a Transvalvular Microaxial Flow Pump for Instantaneous Determination of Native Cardiac Output and VolumeM Imran Aslam, Aleksandra B Gruslova, Ahmed Almomani, et al.
Medrxiv : the Preprint Server for Health Sciences|June 12, 2025
Development of Computational Pipeline for Right Ventricular Hemodynamic Single-Beat AnalysisGyeongtae S Moon, Paul J Scheel, Maggie Montovano, et al.
Journal of the American Heart Association|January 9, 2024
Common Heart Failure With Preserved Ejection Fraction Animal Models Yield Disparate Myofibril MechanicsAxel J Fenwick, Vivek P Jani, D Brian Foster, et al.
Pageof 17